China Health Technology Group Holding Company Limited
CHBOD
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.48% | 10.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.48% | 10.09% | |||
| Cost of Revenue | -0.48% | -5.86% | |||
| Gross Profit | -0.52% | 250.97% | |||
| SG&A Expenses | -0.48% | -30.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.48% | -13.52% | |||
| Operating Income | 0.49% | 56.47% | |||
| Income Before Tax | -0.48% | 463.47% | |||
| Income Tax Expenses | -2.22% | 1,400.00% | |||
| Earnings from Continuing Operations | -0.49% | 457.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.49% | 457.72% | |||
| EBIT | 0.49% | 56.47% | |||
| EBITDA | 0.50% | 56.67% | |||
| EPS Basic | 0.00% | 414.29% | |||
| Normalized Basic EPS | 2.22% | 65.65% | |||
| EPS Diluted | 0.00% | 414.29% | |||
| Normalized Diluted EPS | 2.22% | 65.65% | |||
| Average Basic Shares Outstanding | 0.00% | 10.75% | |||
| Average Diluted Shares Outstanding | 0.00% | 10.75% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||